As regulator prepares to approve Lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’
FDA can grant exclusivity to that drug. And then once there’s finally a generic that can also be granted a one year exclusivity. The FDA facilitates scarcity.
FDA can grant exclusivity to that drug. And then once there’s finally a generic that can also be granted a one year exclusivity. The FDA facilitates scarcity.